Outcomes Following Neoadjuvant or Adjuvant Chemotherapy for cT2-4N0-1 Non-Small Cell Lung Cancer: A Propensity-Matched Analysis

OBJECTIVE: Comparative survival between neoadjuvant chemotherapy (NC) and adjuvant chemotherapy (AC) for patients with cT2-4N0-1M0 non-small cell lung cancer (NSCLC) has not been extensively studied. METHODS: Patients with cT2-4N0-1M0 NSCLC who received platinum-based chemotherapy were retrospective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Cardiovasc Surg
Main Authors: Brandt, Whitney S., Yan, Wanpu, Zhou, Jian, Tan, Kay See, Montecalvo, Joseph, Park, Bernard J., Adusumilli, Prasad S., Huang, James, Bott, Matthew J., Rusch, Valerie W., Molena, Daniela, Travis, William D., Kris, Mark G., Chaft, Jamie E., Jones, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344258/
https://ncbi.nlm.nih.gov/pubmed/30415902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.09.098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados